Interleukin-6 (IL-6) is a multifunctional cytokine that mediates cell growth, differentiation, and survival. It was the objective of the present study to investigate the possible function(s) of IL-6 signaling in embryonic mouse submandibular salivary gland (SMG) morphogenesis. After characterizing in vivo mRNA and protein expression of various constituents of this pathway, we utilized in vitro strategies to investigate the phenotypic outcomes of enhanced IL-6-induced signaling and immunoperturbation of IL-6 binding to cognate receptors. These experiments demonstrate: (1) there is a significant increase of IL-6 mRNA with progressive SMG development, and that this is highly correlated with TNF transcript levels; (2) IL-6 and its cognate receptors are immunolocalized in SMG branching epithelia from the canalicular stage to the late terminal bud stage, as are other constituents of the IL-6 pathway; (3) as compared to controls, IL-6-supplemented explants exhibit a substantial increase in overall size and in the number of ductal branches and terminal buds, as well as a highly significant increase in epithelial cell proliferation; (4) SMG explants cultured in the presence of anti-IL-6 neutralizing antibodies exhibit a marked decrease in epithelial ducts and terminal buds, concomitant with a significant decline in cell proliferation and a highly significant increase in apoptosis. Taken together, our experimental results indicate that IL-6 signaling is important to SMG developmental homeostasis.

Keywords:
Submandibular salivary gland, Interleukin-6, Tumor necrosis factor, gp130, STAT3, bcl-2, Mucin, Development, Mouse
1.
Bellido, T., C.A. O’Brien, P.K. Roberson, S.C. Manolagas (1998) Transcriptional activation of the p21 (WAF1, CIP, 1, SDI1) gene by interleukin-6 type cytokines. A prerequisite for their pro-differentiating and anti-apoptotic effects on human osteoblastic cells. J Biol Chem 273: 21137–21144.
2.
Fukada, T., M. Hibi, Y. Yamanaka, M. Takahashi-Tezuka, Y. Fujitani, T. Yamaguchi, K. Nakajima, T. Hirano (1996) Two signals are necessary for cell proliferation induced by a cytokine receptor gp130: Involvement of STAT3 in anti-apoptosis. Immunity 5: 449–460.
3.
Gottlieb, R.A. (1999) Mitochondria: ignition chamber for apoptosis. Mol Genet Metab 68: 227–231.
4.
Heinrich, P.C., I. Behrmann, G. Muller-Newen, F. Schaper, L. Graeve (1998) Interleukin-6-type cytokine signalling through the gp130/JAK/STAT pathway. Biochem J 334: 297–314.
5.
Hirano, T. (1998) Interleukin-6; in Thomson, A. (ed): The Cytokine Handbook, ed 3. New York, Academic Press, pp 197–228.
6.
Jaskoll, T., M. Melnick (1999) Submandibular gland morphogenesis: Stage-specific expression of TGF-α/EGF, IGF, TGF-β, TNF, and IL-6 signal transduction in normal embryonic mice and the phenotypic effects of TGF-β2, TGF-β3 and EGF-R null mutations. Anat Rec 256: 252–268.
7.
Jaskoll, T., H.A. Choy, M. Melnick (1994) Glucocorticoids, TGF-β, and embryonic mouse salivary gland morphogenesis. J Craniofasc Genet Dev Biol 14: 217–230.
8.
Jaskoll, T., H. Chen, P.C. Denny, P.A. Denny, M. Melnick (1998) Mouse submandibular gland mucin: embryo-specific mRNA and protein species. Mech Dev 74: 179–183.
9.
Jourdan, M., K. Tarte, E. Legouffe, J. Brochier, J.F. Rossi (1999) Tumor necrosis factor is a survival and proliferation factor for human myeloma cells. Eur Cytokine Netw 10: 65–70.
10.
Katz, J., R. Nagler, S. Barak, A. Livneh, B. Baum, J. Atkinson, J. Shemer (1994) Cytokines modulate interleukin-6 production by human salivary gland cell line. Cell Immunol 159: 211–219.
11.
Kurokouchi, K., F. Kambe, K. Yasukawa, R. Izumi, N. Ishiguro, H. Iwata, H. Seo (1998) TNF-alpha increases expression of IL-6 and ICAM-1 genes through activation of NF-kappaB in osteoblast-like ROS17/2.8 cells. J Bone Miner Res 13: 1290–1299.
12.
Melnick, M., T. Jaskoll (2000) Mouse submandibular gland morphogenesis: A paradigm for embryonic signal processing. Crit Rev Oral Biol Med 11:199–215.
13.
Nakajima, K., Y. Yamanaka, K. Nakae, H. Kojima, M. Ichiba, N. Kiuchi, T. Kitaoka, T. Fukada, M. Hibi, T. Hirano (1996) A central role for STAT3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J 15: 3651–3658.
14.
Ohtani, T., K. Ishihara, T. Atsumi, K. Nishida, Y. Kaneko, T. Miyata, S. Itoh, M. Narimatsu, H. Maeda, T. Fukada, M. Itoh, H. Okano, M. Hibi, T. Hirano (2000) Dissection of signaling cascades through gp130 in vivo: Reciprocal roles for STAT3 and SHP2-mediated signals in immune responses. Immunity 12: 95–105.
15.
Raff, M. (1998) Cell suicide for beginners. Nature 396: 119–122.
16.
Raz, R., C.K. Lee, L.A. Cannizzaro, P d’Eustachio, D.E. Levy (1999) Essential role of STAT3 for embryonic stem cell pluripotency. Proc Natl Acad Sci USA 96: 2846–2851.
17.
Rettig, M.B. (1997) Interleukin-6: An antagonizing problem becomes a solution. Nature Biotechnol 15: 952–953.
18.
Rollwagen, F.M., Z.Y. Yu, Y.Y. Li, N.D. Pacheco, (1999) IL-6 rescues enterocytes from hemorrhage induced apoptosis in vivo and in vitro by a bcl-2 mediated mechanism. Clin Immunol Immunopathol 89: 205–213.
19.
Sakamoto, T., Z. Liu, N. Murase, T. Ezure, S. Yokomuro, V. Poli, A.J. Demetris (1999) Mitosis and apoptosis in the liver of Interleukin-6 deficient mice after partial hepatectomy. Hepatology 29: 403–411.
20.
Sokal, R.R., F.J. Rohlf (1981) Biometry. New York, Freeman.
21.
Stahl, N., T.J. Farruggella, T.G. Boulton, Z. Zhong, J.E. Darnell, G.D. Yancopoulos (1995) Choice of STATs and other substrates specified by modular tyrosine-based motifs in cytokine receptors. Science 267: 1349–1353.
22.
Theiler, K. (1989) The House Mouse. New York, Springer.
23.
Weng, G., U.P. Bhalla, R. Iyengar (1999) Complexity in biological signaling systems. Science 284: 92–96.
24.
Wessells, N.K. (1977) Tissue Interactions and Development. Menlo Park, Benjamin Cummins.
25.
Yamanaka, Y., K. Nakajima, T. Fukada, M. Hibi, T. Hirano (1996) Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for STAT3 activation. EMBO J 15: 1557–1565.
26.
Zhang, Z., G.M. Fuller (1997) The competitive binding of STAT3 and NFκB on an overlapping DNA binding site. Biochem Biophys Res Commun 237: 90–94.
© 2001 S. Karger AG, Basel
2001
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.